SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007812
Filing Date
2022-05-05
Accepted
2022-05-05 16:07:33
Documents
73
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mirm-20220331.htm   iXBRL 10-Q 2849079
2 EX-31.1 mirm-ex31_1.htm EX-31.1 20795
3 EX-31.2 mirm-ex31_2.htm EX-31.2 20953
4 EX-32.1 mirm-ex32_1.htm EX-32.1 11770
5 EX-32.2 mirm-ex32_2.htm EX-32.2 11925
  Complete submission text file 0000950170-22-007812.txt   10235284

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mirm-20220331.xsd EX-101.SCH 72793
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mirm-20220331_lab.xml EX-101.LAB 572604
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mirm-20220331_pre.xml EX-101.PRE 432610
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mirm-20220331_def.xml EX-101.DEF 274058
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mirm-20220331_cal.xml EX-101.CAL 59765
67 EXTRACTED XBRL INSTANCE DOCUMENT mirm-20220331_htm.xml XML 1880242
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38981 | Film No.: 22896227
SIC: 2834 Pharmaceutical Preparations